KCI Licensing, Inc. (Subsidiary of ACELITY L.P. INC), Smith and Nephew, Medline Industries, Inc. are Dominating the U.S. Advanced Wound Care Market in 2018

U.S. Advanced Wound Care Market is expected to reach USD 11,326.75 million by 2026 from USD 6,153.75 million in 2018, at a CAGR of 8.0% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://databridgemarketresearch.com/reports/us-advanced-wound-care-market

The U.S. advanced wound care market is an upcoming market which includes specific number of key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rapid growth in the geriatric population and increasing number of road accidents and trauma injuries.

The market has witnessed developments in terms of merger and acquisitions, partnerships or product launches that expand the product portfolio for the customers. The companies are focused to meet the rising demand of innovative technology which helps the companies to sustain their position in the market. For instance, In January 2019, Mölnlycke announced acquisition of M&J Airlaid products. This would help in reinforcement of its wound care abilities. It will also help in supply of the airlaid material which is important in the fabrication of advanced wound care dressings.

KCI Licensing, Inc. (Subsidiary of ACELITY L.P. INC) dominated the U.S. advanced wound care market and accounts for the highest market share in 2018 which is followed by Smith and Nephew, Medline Industries, Inc, 3M, ConvaTec Group PLC, Medtronic. The other key players existing in the market Mölnlycke Health Care AB, Advancis Medical, PAUL HARTMANN AG, Integra LifeSciences Corporation, Organogenesis Holdings Inc., Coloplast Group, B. Braun Melsungen AG, Baxter, Johnson & Johnson Services, Inc., Anika Therapeutics, Inc., ACell, Inc among others.

KCI Licensing, Inc. (subsidiary of ACELITY L.P. INC)

KCI Licensing, Inc. (subsidiary of ACELITY L.P. INC) is headquartered in Texas, U.S. The company is focuses on providing products in advanced wound care to improve patients’ lives. The company is providing wound management, open abdomen management, incision management, epidermal harvesting, animal health. The market focus products lie under wound management. The company is continuously engaged in manufacturing wound care products.

  • In May 2019, KCI licensing, Inc.( subsidiary of Acelity L.P. INC ) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Dermatac Drape. It is a silicone-acrylic hybrid drape used for clinical and operational advantages. It is used in Negative Pressure Wound Therapy. It will help company to increase market share in U.S. wound care market.

The company has its global presence in Europe, Asia-Pacific, Middle East & Africa, North America, Latin America. It operates through its subsidiaries such as Plexus Enterprises, Inc (U.S.), Systagenix Wound Management Mezz B.V. (Netherland), Technimotion, LLC (U.S.), The Kinetic Concepts Foundation (U.S.), Equi-Tron Manufacturing, Inc (Canada) among others.

Smith and Nephew

Smith and Nephew is headquartered in London, U.K. was founded in 1856. The company focused on designing. developing and selling of medical devices. The company mainly manages their operation in Knee Implants, Advanced Wound Bioactives, Arthroscopic Enabling Technologies, Hip Implants, Advanced Wound Care, Sports Medicine Joint Repair, Advanced Wound Devices, Other Surgical Businesses, Trauma & Extremities. The market focus category lies under advanced wound care.

  • In July 2019, Smith & Nephew announced that it has completed the acquisition of Atracsys Sarl. The acquisition would help in long-term promise to improve its multi-asset digital surgery to advance clinical results.

The company has its global presence in Asia Pacific, Europe, Middle East and Africa, The Americas. It operates through its subsidiaries such as Blue Belt Technologies UK Limited (U.K.), Neotherix Limited (U.S.), Plus Orthopedics (U.K.) Limited (U.K.), Arthrocare Corporation (U.S.), Bioventus LLC (U.S.), Smith & Nephew Pty Limited (Australia), ArthoCare Medical Devices (Beijing) Co.Limited (China).

Medline Industries, Inc

Medline Industries, Inc is headquartered in Northfield, U.S was founded in 1966. The company focuses on to provide quality medical products with superior value to health care providers and end users, improving patient care and enhancing the quality of peoples’ lives. The company is providing product categories such as Advanced Wound Care, Anesthesia, Apparel, Beds & Mattresses, Central Sterile, Diagnostics, Durable Medical Equipment (DME), Environmental Services (EVS), Equipment & Furnishings, Foot & Ankle, Gloves, Incontinence, Infection Prevention, Lab Supplies, Nursing Supplies/Patient Care, Nutrition, Office Supplies, OR/Surgery, Pharmacy, Punctal Occlusion, Respiratory, Skin Care, Textiles, Therapy & Rehabilitation, Urology & Ostomy, Vascular Access, Wound Care. The market focus products lie under wound care. The company has diagnosis & treatment businesses market focused segment.

  • In October 2016, Medline Industries, Inc entered into distribution agreement with ADDLIFE AB (Sweden) to distribute all the medical products in Europe. This agreement will help the company to increase its presence and will increase revenue in Europe as addLife is one of the leading distributors in European Life Science market.

The company has its global presence in Europe, North America, Asia. It operates through its subsidiaries such as Centurion Medical Products Corporation (U.S.), Excelsior Medical Corporation (Neptune, New Jersey), SunChoiceMedical Supply Inc. (U.S.), Professional Hospital Supply, Inc. (California, U.S.), Precept Medical Products, Inc(Arden, NC, U.S.), and Others.